Oncology Clinical Trial Trends in the US
Leap enrols first subject in Phase II colorectal cancer antibody trial
The company anticipates reporting the preliminary findings from the trial mid-next year.
Accutar doses first subject in Phase I trial of AC0682 for breast cancer
TILT Biotherapeutics doses first US subject in ovarian cancer therapy trial
Oncology has highest number of FDA accelerated approvals
Clarity begins subject dosing in prostate cancer therapy trial
EpicentRx doses first subject in Phase III lung cancer trial in China
